Metabolic & Energy

Best Peptides for Chronic Fatigue: Evidence-Based Guide

Guide to peptides for chronic fatigue syndrome — NAD+, thymosin alpha-1, BPC-157, and sermorelin with evidence, dosing, and protocols.

Affects approximately 0.4% of the global population; 2.5 million Americans

This page is for educational purposes only and does not constitute medical advice. Peptides discussed are research compounds. Always consult a qualified healthcare provider for diagnosis and treatment.

Understanding Chronic Fatigue Syndrome (ME/CFS)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem illness characterized by profound fatigue not relieved by rest, post-exertional malaise, cognitive impairment, and sleep disturbances. The pathophysiology involves mitochondrial dysfunction, immune dysregulation, autonomic nervous system abnormalities, and neuroinflammation.

Common Symptoms

Profound fatigue lasting 6+ months

Post-exertional malaise (PEM)

Cognitive impairment ('brain fog')

Unrefreshing sleep

Orthostatic intolerance

Widespread pain

Conventional Treatments

Pacing and energy managementCognitive behavioral therapy (limited evidence)Graded exercise therapy (controversial)Symptom management (sleep aids, pain management)Low-dose naltrexone (off-label)

How Peptides May Help

NAD+ addresses mitochondrial dysfunction and energy metabolism deficits common in ME/CFS. Thymosin Alpha-1 modulates immune dysfunction and may address the immune activation component. BPC-157 supports gut-brain axis integrity, which is increasingly recognized as important in ME/CFS. Sermorelin may help with the GH axis dysregulation seen in some ME/CFS patients.

Top Peptides for Chronic Fatigue Syndrome (ME/CFS)

1NAD+

Moderate — emerging clinical data

Mechanism: Restores mitochondrial function, supports cellular energy production, activates sirtuins

Typical dose: 500-1000mg/day oral NMN/NR, or 25-100mg/day SubQ NAD+

2Thymosin Alpha-1

Limited human data; promising case reports

Mechanism: Immune modulation, T-cell activation, reduction of immune dysregulation

Typical dose: 1.6mg SubQ twice weekly for 6-12 weeks

3BPC-157

Preclinical only for ME/CFS

Mechanism: Gut-brain axis support, anti-inflammatory, autonomic nervous system modulation

Typical dose: 250-500mcg oral or SubQ daily

Suggested Starting Protocol

Start with NAD+ (NMN 500mg/day orally) for 4 weeks to assess tolerance and energy response. Add Thymosin Alpha-1 (1.6mg twice weekly) in week 5. Add BPC-157 (250mcg oral daily) in week 9 if gut symptoms are present. Pace activity carefully — avoid post-exertional malaise triggers.

Important: ME/CFS is a complex illness with heterogeneous presentations. No peptide protocol has been validated in ME/CFS clinical trials. Start low and go slow — post-exertional malaise can be triggered by overexertion, including the stress of new interventions. Work with a physician familiar with ME/CFS.

Frequently Asked Questions

Can peptides cure ME/CFS?

No peptide has been shown to cure ME/CFS. Peptides may address specific pathophysiological components (mitochondrial dysfunction, immune dysregulation) and improve quality of life, but ME/CFS is a complex condition requiring comprehensive management.

Is NAD+ safe for ME/CFS patients?

NAD+ precursors (NMN, NR) are generally well-tolerated. Start at a low dose (250mg/day) and increase slowly. Some ME/CFS patients are sensitive to stimulating interventions — monitor for post-exertional malaise.

What is the best peptide for brain fog in ME/CFS?

NAD+ has the most evidence for cognitive symptoms in ME/CFS, supporting mitochondrial function in neurons. BPC-157 may help via gut-brain axis modulation. Thymosin Alpha-1 may reduce neuroinflammation.

Related Conditions

long covid fibromyalgia sleep disorders Cognitive Decline and Mild Cognitive Impairment

Find the right peptide for your biology

Take our 5-minute quiz to get a personalized peptide recommendation based on your specific goals and health profile.